Lupin informs about press release

01 Apr 2019 Evaluate

Lupin has informed that it has enclosed a Press Release as regards launch of Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg for which US FDA approval was received earlier. This is considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2312.70 -22.25 (-0.95%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×